Cargando…
Correction: Advances in immunotherapy for triple-negative breast cancer
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500861/ https://www.ncbi.nlm.nih.gov/pubmed/37710293 http://dx.doi.org/10.1186/s12943-023-01858-z |
| _version_ | 1785106003592740864 |
|---|---|
| author | Liu, Yang Hu, Yueting Xue, Jinqi Li, Jingying Yi, Jiang Bu, Jiawen Zhang, Zhenyong Qiu, Peng Gu, Xi |
| author_facet | Liu, Yang Hu, Yueting Xue, Jinqi Li, Jingying Yi, Jiang Bu, Jiawen Zhang, Zhenyong Qiu, Peng Gu, Xi |
| author_sort | Liu, Yang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10500861 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105008612023-09-15 Correction: Advances in immunotherapy for triple-negative breast cancer Liu, Yang Hu, Yueting Xue, Jinqi Li, Jingying Yi, Jiang Bu, Jiawen Zhang, Zhenyong Qiu, Peng Gu, Xi Mol Cancer Correction BioMed Central 2023-09-14 /pmc/articles/PMC10500861/ /pubmed/37710293 http://dx.doi.org/10.1186/s12943-023-01858-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Liu, Yang Hu, Yueting Xue, Jinqi Li, Jingying Yi, Jiang Bu, Jiawen Zhang, Zhenyong Qiu, Peng Gu, Xi Correction: Advances in immunotherapy for triple-negative breast cancer |
| title | Correction: Advances in immunotherapy for triple-negative breast cancer |
| title_full | Correction: Advances in immunotherapy for triple-negative breast cancer |
| title_fullStr | Correction: Advances in immunotherapy for triple-negative breast cancer |
| title_full_unstemmed | Correction: Advances in immunotherapy for triple-negative breast cancer |
| title_short | Correction: Advances in immunotherapy for triple-negative breast cancer |
| title_sort | correction: advances in immunotherapy for triple-negative breast cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500861/ https://www.ncbi.nlm.nih.gov/pubmed/37710293 http://dx.doi.org/10.1186/s12943-023-01858-z |
| work_keys_str_mv | AT liuyang correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT huyueting correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT xuejinqi correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT lijingying correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT yijiang correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT bujiawen correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT zhangzhenyong correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT qiupeng correctionadvancesinimmunotherapyfortriplenegativebreastcancer AT guxi correctionadvancesinimmunotherapyfortriplenegativebreastcancer |